ProShare Advisors’s Sangamo Therapeutics SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-19,955
Closed -$7.15K 2105
2024
Q2
$7.15K Sell
19,955
-6,811
-25% -$2.44K ﹤0.01% 1840
2024
Q1
$17.9K Buy
26,766
+1,864
+7% +$1.25K ﹤0.01% 1976
2023
Q4
$13.5K Sell
24,902
-5,416
-18% -$2.94K ﹤0.01% 1937
2023
Q3
$18.2K Buy
30,318
+443
+1% +$266 ﹤0.01% 1791
2023
Q2
$38.8K Buy
29,875
+2,444
+9% +$3.18K ﹤0.01% 1794
2023
Q1
$48.3K Sell
27,431
-3,341
-11% -$5.88K ﹤0.01% 1675
2022
Q4
$96.6K Buy
30,772
+3,511
+13% +$11K ﹤0.01% 1656
2022
Q3
$134K Buy
27,261
+2,382
+10% +$11.7K ﹤0.01% 1494
2022
Q2
$104K Sell
24,879
-12,515
-33% -$52.3K ﹤0.01% 1606
2022
Q1
$217K Sell
37,394
-9,058
-19% -$52.6K ﹤0.01% 1840
2021
Q4
$348K Buy
46,452
+185
+0.4% +$1.39K ﹤0.01% 1697
2021
Q3
$417K Sell
46,267
-10,081
-18% -$90.9K ﹤0.01% 1316
2021
Q2
$674K Buy
56,348
+5,760
+11% +$68.9K ﹤0.01% 1304
2021
Q1
$634K Buy
50,588
+3,256
+7% +$40.8K ﹤0.01% 1291
2020
Q4
$739K Buy
47,332
+10,496
+28% +$164K ﹤0.01% 1021
2020
Q3
$348K Sell
36,836
-1,325
-3% -$12.5K ﹤0.01% 1097
2020
Q2
$342K Buy
38,161
+15,490
+68% +$139K ﹤0.01% 1155
2020
Q1
$144K Sell
22,671
-17,973
-44% -$114K ﹤0.01% 1042
2019
Q4
$340K Sell
40,644
-3,753
-8% -$31.4K ﹤0.01% 1268
2019
Q3
$402K Sell
44,397
-31
-0.1% -$281 ﹤0.01% 1070
2019
Q2
$478K Sell
44,428
-1,282
-3% -$13.8K ﹤0.01% 1032
2019
Q1
$436K Buy
45,710
+415
+0.9% +$3.96K ﹤0.01% 1071
2018
Q4
$520K Sell
45,295
-8,571
-16% -$98.4K ﹤0.01% 934
2018
Q3
$913K Sell
53,866
-2,149
-4% -$36.4K 0.01% 862
2018
Q2
$795K Buy
56,015
+6,218
+12% +$88.3K 0.01% 914
2018
Q1
$946K Sell
49,797
-8,187
-14% -$156K 0.01% 845
2017
Q4
$951K Buy
57,984
+5,193
+10% +$85.2K 0.01% 859
2017
Q3
$792K Buy
52,791
+9,560
+22% +$143K 0.01% 792
2017
Q2
$380K Sell
43,231
-2,590
-6% -$22.8K ﹤0.01% 1055
2017
Q1
$238K Sell
45,821
-11,989
-21% -$62.3K ﹤0.01% 1362
2016
Q4
$176K Buy
57,810
+6,422
+12% +$19.6K ﹤0.01% 1625
2016
Q3
$238K Sell
51,388
-9,583
-16% -$44.4K ﹤0.01% 1260
2016
Q2
$353K Buy
60,971
+365
+0.6% +$2.11K ﹤0.01% 1126
2016
Q1
$367K Sell
60,606
-5,855
-9% -$35.5K 0.01% 1120
2015
Q4
$607K Buy
66,461
+6,537
+11% +$59.7K 0.01% 948
2015
Q3
$338K Sell
59,924
-4,455
-7% -$25.1K ﹤0.01% 1099
2015
Q2
$714K Sell
64,379
-4,485
-7% -$49.7K 0.01% 932
2015
Q1
$1.08M Buy
68,864
+8,969
+15% +$141K 0.01% 810
2014
Q4
$911K Sell
59,895
-2,219
-4% -$33.8K 0.01% 906
2014
Q3
$670K Sell
62,114
-12,263
-16% -$132K 0.01% 1235
2014
Q2
$1.14M Sell
74,377
-35,451
-32% -$541K 0.01% 1100
2014
Q1
$1.99M Buy
109,828
+78,162
+247% +$1.41M 0.02% 755
2013
Q4
$440K Sell
31,666
-21,288
-40% -$296K 0.01% 1083
2013
Q3
$555K Buy
52,954
+8,477
+19% +$88.8K 0.01% 1371
2013
Q2
$347K Buy
+44,477
New +$347K 0.01% 1589